Basit öğe kaydını göster

Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome

dc.contributor.authorOruc, Coskun U.
dc.contributor.authorAmikishiyev, Shırkhan
dc.contributor.authorGurdol, Figen
dc.contributor.authorSalmaslioglu, Artur
dc.contributor.authorOmer, Beyhan
dc.contributor.authorAkpinar, Yunus E.
dc.contributor.authorDervisoglu, Elmire
dc.date.accessioned2021-03-03T11:25:52Z
dc.date.available2021-03-03T11:25:52Z
dc.date.issued2017
dc.identifier.citationOruc C. U. , Akpinar Y. E. , Dervisoglu E., Amikishiyev S., Salmaslioglu A., Gurdol F., Omer B., "Low concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.55, sa.1, ss.139-144, 2017
dc.identifier.issn1434-6621
dc.identifier.otherav_27decbea-7049-45b3-bf4d-c3e2509c8150
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/31651
dc.identifier.urihttps://doi.org/10.1515/cclm-2016-0329
dc.description.abstractBackground: In individuals with atherosclerotic risk factors, endothelial dysfunction (ED) appears as an early phase in the development of clinical symptoms. Recent studies indicate that adropin, a newly identified peptide, participates in cardiovascular health through the regulation of several metabolic events including angiogenesis and blood flow. In this study, we aimed to determine the relation of adropin with biochemical and radiologic parameters which reflect ED such as endothelial nitric oxide synthase (eNOS), endothelin 1 (ET-1), nitric oxide (NO) and flow-mediated dilatation (FMD) along with the routine biochemical measurements in patients recently diagnosed with metabolic syndrome (MetS).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleLow concentrations of adropin are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome
dc.typeMakale
dc.relation.journalCLINICAL CHEMISTRY AND LABORATORY MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume55
dc.identifier.issue1
dc.identifier.startpage139
dc.identifier.endpage144
dc.contributor.firstauthorID17366


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster